Global Rosuvastatin Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Rosuvastatin is used along with a proper diet to help lower 'bad' cholesterol and fats (such as LDL, triglycerides) and raise 'good' cholesterol (HDL) in the blood. It belongs to a group of drugs known as 'statins.' It works by reducing the amount of cholesterol made by the liver. Lowering 'bad' cholesterol and triglycerides and raising 'good' cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
According to our (Global Info Research) latest study, the global Rosuvastatin Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Rosuvastatin Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rosuvastatin Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rosuvastatin Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rosuvastatin Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rosuvastatin Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rosuvastatin Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rosuvastatin Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Watson, ANGITA and Sun Pharmaceutical Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Rosuvastatin Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Rosuvastatin Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rosuvastatin Drugs, with price, sales, revenue and global market share of Rosuvastatin Drugs from 2018 to 2023.
Chapter 3, the Rosuvastatin Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rosuvastatin Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rosuvastatin Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rosuvastatin Drugs.
Chapter 14 and 15, to describe Rosuvastatin Drugs sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Rosuvastatin Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Rosuvastatin Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rosuvastatin Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rosuvastatin Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rosuvastatin Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Rosuvastatin Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rosuvastatin Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rosuvastatin Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Watson, ANGITA and Sun Pharmaceutical Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Rosuvastatin Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 5 mg Tablet
- 10 mg Tablet
- 20 mg Tablet
- 40 mg Tablet
- Hyperlipidemia And Mixed Dyslipidemia
- Familial Hypercholesterolemia
- Hypertriglyceridemia
- Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
- Atherosclerosis
- Others
- AstraZeneca
- Watson
- ANGITA
- Sun Pharmaceutical Industries
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rosuvastatin Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rosuvastatin Drugs, with price, sales, revenue and global market share of Rosuvastatin Drugs from 2018 to 2023.
Chapter 3, the Rosuvastatin Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rosuvastatin Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rosuvastatin Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rosuvastatin Drugs.
Chapter 14 and 15, to describe Rosuvastatin Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rosuvastatin Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rosuvastatin Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 5 mg Tablet
1.3.3 10 mg Tablet
1.3.4 20 mg Tablet
1.3.5 40 mg Tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Rosuvastatin Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hyperlipidemia And Mixed Dyslipidemia
1.4.3 Familial Hypercholesterolemia
1.4.4 Hypertriglyceridemia
1.4.5 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
1.4.6 Atherosclerosis
1.4.7 Others
1.5 Global Rosuvastatin Drugs Market Size & Forecast
1.5.1 Global Rosuvastatin Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rosuvastatin Drugs Sales Quantity (2018-2029)
1.5.3 Global Rosuvastatin Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Rosuvastatin Drugs Product and Services
2.1.4 AstraZeneca Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Watson
2.2.1 Watson Details
2.2.2 Watson Major Business
2.2.3 Watson Rosuvastatin Drugs Product and Services
2.2.4 Watson Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Watson Recent Developments/Updates
2.3 ANGITA
2.3.1 ANGITA Details
2.3.2 ANGITA Major Business
2.3.3 ANGITA Rosuvastatin Drugs Product and Services
2.3.4 ANGITA Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ANGITA Recent Developments/Updates
2.4 Sun Pharmaceutical Industries
2.4.1 Sun Pharmaceutical Industries Details
2.4.2 Sun Pharmaceutical Industries Major Business
2.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Product and Services
2.4.4 Sun Pharmaceutical Industries Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sun Pharmaceutical Industries Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ROSUVASTATIN DRUGS BY MANUFACTURER
3.1 Global Rosuvastatin Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rosuvastatin Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Rosuvastatin Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rosuvastatin Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rosuvastatin Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Rosuvastatin Drugs Manufacturer Market Share in 2022
3.5 Rosuvastatin Drugs Market: Overall Company Footprint Analysis
3.5.1 Rosuvastatin Drugs Market: Region Footprint
3.5.2 Rosuvastatin Drugs Market: Company Product Type Footprint
3.5.3 Rosuvastatin Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rosuvastatin Drugs Market Size by Region
4.1.1 Global Rosuvastatin Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Rosuvastatin Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Rosuvastatin Drugs Average Price by Region (2018-2029)
4.2 North America Rosuvastatin Drugs Consumption Value (2018-2029)
4.3 Europe Rosuvastatin Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Rosuvastatin Drugs Consumption Value (2018-2029)
4.5 South America Rosuvastatin Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Rosuvastatin Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
5.2 Global Rosuvastatin Drugs Consumption Value by Type (2018-2029)
5.3 Global Rosuvastatin Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
6.2 Global Rosuvastatin Drugs Consumption Value by Application (2018-2029)
6.3 Global Rosuvastatin Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
7.2 North America Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
7.3 North America Rosuvastatin Drugs Market Size by Country
7.3.1 North America Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Rosuvastatin Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Rosuvastatin Drugs Market Size by Country
8.3.1 Europe Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Rosuvastatin Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rosuvastatin Drugs Market Size by Region
9.3.1 Asia-Pacific Rosuvastatin Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rosuvastatin Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
10.2 South America Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
10.3 South America Rosuvastatin Drugs Market Size by Country
10.3.1 South America Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Rosuvastatin Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rosuvastatin Drugs Market Size by Country
11.3.1 Middle East & Africa Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rosuvastatin Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Rosuvastatin Drugs Market Drivers
12.2 Rosuvastatin Drugs Market Restraints
12.3 Rosuvastatin Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rosuvastatin Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rosuvastatin Drugs
13.3 Rosuvastatin Drugs Production Process
13.4 Rosuvastatin Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rosuvastatin Drugs Typical Distributors
14.3 Rosuvastatin Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rosuvastatin Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rosuvastatin Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 5 mg Tablet
1.3.3 10 mg Tablet
1.3.4 20 mg Tablet
1.3.5 40 mg Tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Rosuvastatin Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hyperlipidemia And Mixed Dyslipidemia
1.4.3 Familial Hypercholesterolemia
1.4.4 Hypertriglyceridemia
1.4.5 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
1.4.6 Atherosclerosis
1.4.7 Others
1.5 Global Rosuvastatin Drugs Market Size & Forecast
1.5.1 Global Rosuvastatin Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rosuvastatin Drugs Sales Quantity (2018-2029)
1.5.3 Global Rosuvastatin Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Rosuvastatin Drugs Product and Services
2.1.4 AstraZeneca Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Watson
2.2.1 Watson Details
2.2.2 Watson Major Business
2.2.3 Watson Rosuvastatin Drugs Product and Services
2.2.4 Watson Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Watson Recent Developments/Updates
2.3 ANGITA
2.3.1 ANGITA Details
2.3.2 ANGITA Major Business
2.3.3 ANGITA Rosuvastatin Drugs Product and Services
2.3.4 ANGITA Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ANGITA Recent Developments/Updates
2.4 Sun Pharmaceutical Industries
2.4.1 Sun Pharmaceutical Industries Details
2.4.2 Sun Pharmaceutical Industries Major Business
2.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Product and Services
2.4.4 Sun Pharmaceutical Industries Rosuvastatin Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sun Pharmaceutical Industries Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ROSUVASTATIN DRUGS BY MANUFACTURER
3.1 Global Rosuvastatin Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rosuvastatin Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Rosuvastatin Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rosuvastatin Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rosuvastatin Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Rosuvastatin Drugs Manufacturer Market Share in 2022
3.5 Rosuvastatin Drugs Market: Overall Company Footprint Analysis
3.5.1 Rosuvastatin Drugs Market: Region Footprint
3.5.2 Rosuvastatin Drugs Market: Company Product Type Footprint
3.5.3 Rosuvastatin Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rosuvastatin Drugs Market Size by Region
4.1.1 Global Rosuvastatin Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Rosuvastatin Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Rosuvastatin Drugs Average Price by Region (2018-2029)
4.2 North America Rosuvastatin Drugs Consumption Value (2018-2029)
4.3 Europe Rosuvastatin Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Rosuvastatin Drugs Consumption Value (2018-2029)
4.5 South America Rosuvastatin Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Rosuvastatin Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
5.2 Global Rosuvastatin Drugs Consumption Value by Type (2018-2029)
5.3 Global Rosuvastatin Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
6.2 Global Rosuvastatin Drugs Consumption Value by Application (2018-2029)
6.3 Global Rosuvastatin Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
7.2 North America Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
7.3 North America Rosuvastatin Drugs Market Size by Country
7.3.1 North America Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Rosuvastatin Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Rosuvastatin Drugs Market Size by Country
8.3.1 Europe Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Rosuvastatin Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rosuvastatin Drugs Market Size by Region
9.3.1 Asia-Pacific Rosuvastatin Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rosuvastatin Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
10.2 South America Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
10.3 South America Rosuvastatin Drugs Market Size by Country
10.3.1 South America Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Rosuvastatin Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rosuvastatin Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rosuvastatin Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rosuvastatin Drugs Market Size by Country
11.3.1 Middle East & Africa Rosuvastatin Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rosuvastatin Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Rosuvastatin Drugs Market Drivers
12.2 Rosuvastatin Drugs Market Restraints
12.3 Rosuvastatin Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rosuvastatin Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rosuvastatin Drugs
13.3 Rosuvastatin Drugs Production Process
13.4 Rosuvastatin Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rosuvastatin Drugs Typical Distributors
14.3 Rosuvastatin Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rosuvastatin Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rosuvastatin Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Rosuvastatin Drugs Product and Services
Table 6. AstraZeneca Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Watson Basic Information, Manufacturing Base and Competitors
Table 9. Watson Major Business
Table 10. Watson Rosuvastatin Drugs Product and Services
Table 11. Watson Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Watson Recent Developments/Updates
Table 13. ANGITA Basic Information, Manufacturing Base and Competitors
Table 14. ANGITA Major Business
Table 15. ANGITA Rosuvastatin Drugs Product and Services
Table 16. ANGITA Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ANGITA Recent Developments/Updates
Table 18. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 19. Sun Pharmaceutical Industries Major Business
Table 20. Sun Pharmaceutical Industries Rosuvastatin Drugs Product and Services
Table 21. Sun Pharmaceutical Industries Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sun Pharmaceutical Industries Recent Developments/Updates
Table 23. Global Rosuvastatin Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Rosuvastatin Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Rosuvastatin Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Rosuvastatin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Rosuvastatin Drugs Production Site of Key Manufacturer
Table 28. Rosuvastatin Drugs Market: Company Product Type Footprint
Table 29. Rosuvastatin Drugs Market: Company Product Application Footprint
Table 30. Rosuvastatin Drugs New Market Entrants and Barriers to Market Entry
Table 31. Rosuvastatin Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Rosuvastatin Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Rosuvastatin Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Rosuvastatin Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Rosuvastatin Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Rosuvastatin Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Rosuvastatin Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Rosuvastatin Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Rosuvastatin Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Rosuvastatin Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Rosuvastatin Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Rosuvastatin Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Rosuvastatin Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Rosuvastatin Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Rosuvastatin Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Rosuvastatin Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Rosuvastatin Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Rosuvastatin Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Rosuvastatin Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Rosuvastatin Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Rosuvastatin Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Rosuvastatin Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Rosuvastatin Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Rosuvastatin Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Rosuvastatin Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Rosuvastatin Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Rosuvastatin Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Rosuvastatin Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Rosuvastatin Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Rosuvastatin Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Rosuvastatin Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Rosuvastatin Drugs Raw Material
Table 91. Key Manufacturers of Rosuvastatin Drugs Raw Materials
Table 92. Rosuvastatin Drugs Typical Distributors
Table 93. Rosuvastatin Drugs Typical Customers
Table 1. Global Rosuvastatin Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rosuvastatin Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Rosuvastatin Drugs Product and Services
Table 6. AstraZeneca Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Watson Basic Information, Manufacturing Base and Competitors
Table 9. Watson Major Business
Table 10. Watson Rosuvastatin Drugs Product and Services
Table 11. Watson Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Watson Recent Developments/Updates
Table 13. ANGITA Basic Information, Manufacturing Base and Competitors
Table 14. ANGITA Major Business
Table 15. ANGITA Rosuvastatin Drugs Product and Services
Table 16. ANGITA Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ANGITA Recent Developments/Updates
Table 18. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 19. Sun Pharmaceutical Industries Major Business
Table 20. Sun Pharmaceutical Industries Rosuvastatin Drugs Product and Services
Table 21. Sun Pharmaceutical Industries Rosuvastatin Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sun Pharmaceutical Industries Recent Developments/Updates
Table 23. Global Rosuvastatin Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Rosuvastatin Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Rosuvastatin Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Rosuvastatin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Rosuvastatin Drugs Production Site of Key Manufacturer
Table 28. Rosuvastatin Drugs Market: Company Product Type Footprint
Table 29. Rosuvastatin Drugs Market: Company Product Application Footprint
Table 30. Rosuvastatin Drugs New Market Entrants and Barriers to Market Entry
Table 31. Rosuvastatin Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Rosuvastatin Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Rosuvastatin Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Rosuvastatin Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Rosuvastatin Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Rosuvastatin Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Rosuvastatin Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Rosuvastatin Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Rosuvastatin Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Rosuvastatin Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Rosuvastatin Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Rosuvastatin Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Rosuvastatin Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Rosuvastatin Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Rosuvastatin Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Rosuvastatin Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Rosuvastatin Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Rosuvastatin Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Rosuvastatin Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Rosuvastatin Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Rosuvastatin Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Rosuvastatin Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Rosuvastatin Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Rosuvastatin Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Rosuvastatin Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Rosuvastatin Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Rosuvastatin Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Rosuvastatin Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Rosuvastatin Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Rosuvastatin Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Rosuvastatin Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Rosuvastatin Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Rosuvastatin Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Rosuvastatin Drugs Raw Material
Table 91. Key Manufacturers of Rosuvastatin Drugs Raw Materials
Table 92. Rosuvastatin Drugs Typical Distributors
Table 93. Rosuvastatin Drugs Typical Customers
LIST OF FIGURES
Figure 1. Rosuvastatin Drugs Picture
Figure 2. Global Rosuvastatin Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rosuvastatin Drugs Consumption Value Market Share by Type in 2022
Figure 4. 5 mg Tablet Examples
Figure 5. 10 mg Tablet Examples
Figure 6. 20 mg Tablet Examples
Figure 7. 40 mg Tablet Examples
Figure 8. Global Rosuvastatin Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Rosuvastatin Drugs Consumption Value Market Share by Application in 2022
Figure 10. Hyperlipidemia And Mixed Dyslipidemia Examples
Figure 11. Familial Hypercholesterolemia Examples
Figure 12. Hypertriglyceridemia Examples
Figure 13. Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Examples
Figure 14. Atherosclerosis Examples
Figure 15. Others Examples
Figure 16. Global Rosuvastatin Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Rosuvastatin Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Rosuvastatin Drugs Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Rosuvastatin Drugs Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Rosuvastatin Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Rosuvastatin Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Rosuvastatin Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Rosuvastatin Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Rosuvastatin Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Rosuvastatin Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Rosuvastatin Drugs Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Rosuvastatin Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Rosuvastatin Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Rosuvastatin Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Rosuvastatin Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Rosuvastatin Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Rosuvastatin Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Rosuvastatin Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Rosuvastatin Drugs Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Rosuvastatin Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Rosuvastatin Drugs Consumption Value Market Share by Region (2018-2029)
Figure 58. China Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Rosuvastatin Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Rosuvastatin Drugs Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Rosuvastatin Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Rosuvastatin Drugs Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Rosuvastatin Drugs Market Drivers
Figure 79. Rosuvastatin Drugs Market Restraints
Figure 80. Rosuvastatin Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Rosuvastatin Drugs in 2022
Figure 83. Manufacturing Process Analysis of Rosuvastatin Drugs
Figure 84. Rosuvastatin Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Rosuvastatin Drugs Picture
Figure 2. Global Rosuvastatin Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rosuvastatin Drugs Consumption Value Market Share by Type in 2022
Figure 4. 5 mg Tablet Examples
Figure 5. 10 mg Tablet Examples
Figure 6. 20 mg Tablet Examples
Figure 7. 40 mg Tablet Examples
Figure 8. Global Rosuvastatin Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Rosuvastatin Drugs Consumption Value Market Share by Application in 2022
Figure 10. Hyperlipidemia And Mixed Dyslipidemia Examples
Figure 11. Familial Hypercholesterolemia Examples
Figure 12. Hypertriglyceridemia Examples
Figure 13. Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Examples
Figure 14. Atherosclerosis Examples
Figure 15. Others Examples
Figure 16. Global Rosuvastatin Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Rosuvastatin Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Rosuvastatin Drugs Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Rosuvastatin Drugs Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Rosuvastatin Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Rosuvastatin Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Rosuvastatin Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Rosuvastatin Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Rosuvastatin Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Rosuvastatin Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Rosuvastatin Drugs Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Rosuvastatin Drugs Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Rosuvastatin Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Rosuvastatin Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Rosuvastatin Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Rosuvastatin Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Rosuvastatin Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Rosuvastatin Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Rosuvastatin Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Rosuvastatin Drugs Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Rosuvastatin Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Rosuvastatin Drugs Consumption Value Market Share by Region (2018-2029)
Figure 58. China Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Rosuvastatin Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Rosuvastatin Drugs Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Rosuvastatin Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Rosuvastatin Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Rosuvastatin Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Rosuvastatin Drugs Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Rosuvastatin Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Rosuvastatin Drugs Market Drivers
Figure 79. Rosuvastatin Drugs Market Restraints
Figure 80. Rosuvastatin Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Rosuvastatin Drugs in 2022
Figure 83. Manufacturing Process Analysis of Rosuvastatin Drugs
Figure 84. Rosuvastatin Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
